#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypoxic-ischaemic encephalopathy B-cell small lymphocytic lymphoma refractory Castleman's disease Cholangitis sclerosing Hereditary motor and sensory neuropathy Stevens-Johnson syndrome Adenomatous polyposis coli Alpha-1 antitrypsin deficiency Amyotrophic lateral sclerosis gene carrier Leber's congenital amaurosis Extraskeletal ossification Obliterative bronchiolitis Krabbe's disease Acute myeloid leukaemia Hypertriglyceridaemia More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Trials in Disease Antisynthetase syndrome – Diagnostics Cytokine release syndrome – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Focal segmental glomerulosclerosis – Basic Information Rosai-Dorfman syndrome – Trials in Disease Congenital nephrogenic diabetes insipidus – Life with Disease Primary biliary cholangitis – Treatment Breast angiosarcoma metastatic Factor IX deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Haemophilus Influenzae Tacrolimus Prednisone Av-Ec2023 Bevacizumab Zirconium Zr-89 Codeine Phosphate Hemihydrate Esflurbiprofen Naproxen Dabigatran Heparin Sodium Posdinemab Gsk6097608 Aptamer-4Ft BW-20805 Rbp030.2 Spartalizumab Levocabastine Hydrochloride N-Acetylhistidine Paliperidone Vo659 More therapies…

    Learn about Your Condition

    Heart transplant Cutibacterium acnes infection Eructation Complex regional pain syndrome Septic shock Vulval cancer Cerebral amyloid angiopathy Rheumatoid arthritis Cataract Hairy cell leukaemia recurrent Dry eye Placenta praevia Arrhythmia supraventricular Deafness traumatic Microscopic polyangiitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Genetic Phenomena

  • Study on the Effects of Tildacerfont and Hydrocortisone in Adults with Classic Congenital Adrenal Hyperplasia

    Not recruiting

    2 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Hydrocortisone
    • Tildacerfont
    Denmark Estonia Germany Ireland Italy Latvia +6
  • Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Niemann-Pick disease
    Investigated Drugs:
    • Hydroxypropylbetadex
    • Miglustat
    Germany Italy Poland Spain
Previous Page
1 … 4 5 6

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!